$13.99
-0.63-4.31%
At close: -
$13.70
-0.29-2.07%
After Hours: 5:15 PM EDT
Comments
Loading...
Evolus (NASDAQ:EOLS) Stock Quotes, Forecast and News Summary
Evolus Stock (NASDAQ: EOLS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Evolus (EOLS) stock?
You can purchase shares of Evolus (NASDAQ:EOLS) through any online brokerage.
Who are Evolus (EOLS) competitors?
Other companies in Evolus’s space includes: Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Xeris Biopharma Holdings (NASDAQ:XERS) and Phibro Animal Health (NASDAQ:PAHC).
What is the forecast, or price target, for Evolus (EOLS) stock?
Evolus has a consensus price target of $21.25.
What is the current price for Evolus (EOLS)?
The stock price for Evolus (NASDAQ: EOLS) is $13.7 last updated February 21, 2025 at 5:15 PM EST.
Does Evolus (EOLS) pay a dividend?
There are no upcoming dividends for Evolus.
When is Evolus (NASDAQ:EOLS) reporting earnings?
Evolus’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Evolus (EOLS) going to split?
There is no upcoming split for Evolus.
What sector and industry does Evolus (EOLS) operate in?
Evolus is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.